OTCMKTS:ELTP

Elite Pharmaceuticals Stock News

Healthcare > Drug Manufacturers - Specialty & Generic

Buy ELTP

*Your capital is at risk

$0.381

-0.0189 (-4.73%)

At Close: Jun 05, 2026

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2022 Financial Results on November 16, 2021

08:00pm, Tuesday, 09'th Nov 2021

Financials for Second Quarter Fiscal Year 2022 Ended September 30, 2021 will be released November 15, 2021 NORTHVALE, NJ / ACCESSWIRE / November 9, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "

Elite Pharmaceuticals, Inc. (ELTP) CEO Narsat Hakim on Q1 2022 Results - Earnings Call Transcript

03:28pm, Tuesday, 17'th Aug 2021

Elite Pharmaceuticals, Inc. (ELTP) CEO Narsat Hakim on Q1 2022 Results - Earnings Call Transcript

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2022 Ended June 30, 2021 and Provides Conference Call Information

04:31pm, Monday, 16'th Aug 2021

Conference Call Scheduled for Tuesday, August 17 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / August 16, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company”) (OTCQB:ELTP), a specialty pharm

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2022 Financial Results on August 17, 2021

04:30pm, Tuesday, 10'th Aug 2021

Financials for First Quarter Fiscal Year 2022 Ended June 30, 2021 will be released August 16, 2021 NORTHVALE, NJ / ACCESSWIRE / August 10, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")

Elite Pharmaceuticals, Inc.'s (ELTP) CEO Nasrat Hakim on Q4 2021 Results - Earnings Call Transcript

01:30pm, Tuesday, 15'th Jun 2021

Elite Pharmaceuticals, Inc.'s (ELTP) CEO Nasrat Hakim on Q4 2021 Results - Earnings Call Transcript

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2021 and Provides Conference Call Information

05:10pm, Monday, 14'th Jun 2021

Conference Call Scheduled for Tuesday, June 15 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / June 14, 2021 / Elite Pharmaceuticals, Inc. ('Elite' or the "Company')(OTCBB:ELTP), a specialty pharmaceutic

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Year-End Financial Results on June 15, 2021

04:00pm, Tuesday, 08'th Jun 2021

Financials for Fiscal Year Ended March 31, 2021 will be released June 14, 2021 NORTHVALE, NJ / ACCESSWIRE / June 8, 2021 / Elite Pharmaceuticals, Inc. ('Elite' or the "Company') (OTCBB:ELTP), a specia

Elite Pharmaceuticals Enters into an Exclusive Distribution Agreement with Prasco, LLC and Announces Commercial Launch of Loxapine Capsules

10:20am, Tuesday, 04'th May 2021

NORTHVALE, NJ / ACCESSWIRE / May 4, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today that its distribution and marketing partner Prasco, LLC ("Prasco"), has l

Elite Pharmaceuticals, Inc. Names Marc Bregman as Chief Financial Officer

08:50am, Thursday, 29'th Apr 2021

NORTHVALE, NJ / ACCESSWIRE / April 29, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic product

Elite Pharmaceuticals, Inc. (ELTP) CEO Nasrat Hakim on Q3 2021 Results - Earnings Call Transcript

03:27pm, Wednesday, 17'th Feb 2021

Elite Pharmaceuticals, Inc. (ELTP) CEO Nasrat Hakim on Q3 2021 Results - Earnings Call Transcript

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by